Medicine composition capable of alleviating asthenopia and preparation method of medicine composition

A technology for relieving visual fatigue and composition, which is applied in the directions of drug combination, pharmaceutical formula, active ingredient of hydroxyl compound, etc.

Inactive Publication Date: 2016-05-04
同溢堂药业有限公司
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no drug that...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition capable of alleviating asthenopia and preparation method of medicine composition
  • Medicine composition capable of alleviating asthenopia and preparation method of medicine composition
  • Medicine composition capable of alleviating asthenopia and preparation method of medicine composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] A preparation method of a pharmaceutical composition for alleviating asthenopia, comprising:

[0031] 1) Weigh the raw materials according to the following parts by mass: 280-320g of Ginkgo biloba, 18-22g of bilberry extract, 230-270g of medlar, 0-20g of Ligustrum lucidum, 0-15g of Polygonum multiflorum, 280-320g of chrysanthemum, cassia seed 0-35g, 8-10g taurine, 9.3-9.7g zinc gluconate, 40-60mg vitamin A; among them, the vitamin A raw material with a purity of 10% is used, that is, the raw material of vitamin A with a purity of 10% is weighed 400~600mg;

[0032] 2) Ginkgo biloba leaves, wolfberry fruit, privet privet fruit, Polygonum multiflorum, chrysanthemum, and cassia seeds are placed in a multi-functional extraction tank, added with 8 times the amount of drinking water, soaked for 20 minutes, steam heated to 100°C, decocted for 1.5 hours, poured Take out the decoction, filter it with a 100-mesh screen to obtain the filtrate (I); decoct the dregs with 6 times the...

Embodiment 2

[0039] The difference between embodiment 2 and embodiment 1 is: in the described step 1), the crude drug is weighed in the following parts by mass: Ginkgo biloba 300g, bilberry extract 20g, medlar 250g, chrysanthemum 300g, taurine 9g, zinc gluconate 9.5g, vitamin A 50mg; Wherein, vitamin A adopts the vitamin A raw material that purity is 10%, namely takes by weighing 500mg of vitamin A raw material that this purity is 10%; All the other steps are with embodiment 1.

[0040] In this example, every 100 g of the pharmaceutical composition contains 0.5 g of anthocyanins, 16 mg of vitamin A, 2.4 g of taurine, and 210 mg of zinc.

Embodiment 3

[0042] The difference between embodiment 3 and embodiment 1 is that: in the step 1), the crude drug is weighed in the following parts by mass: 300g of ginkgo biloba, 20g of bilberry extract, 2350g of medlar, 5g of privet fruit, Polygonum multiflorum 5g, chrysanthemum 300g, cassia seed 10g, taurine 9g, zinc gluconate 9.5g, vitamin A 50mg; Wherein, vitamin A adopts the raw material of vitamin A that is 10% purity, promptly takes this purity and is 500mg of vitamin A raw material of 10%; All the other steps are the same as in Example 1.

[0043] In this example, every 100 g of the pharmaceutical composition contains 0.5 g of anthocyanins, 16 mg of vitamin A, 2.4 g of taurine, and 210 mg of zinc.

[0044] Those skilled in the art will know that when the technical parameters of the present invention change within the following ranges, the same or similar effects as those of the above-mentioned embodiments can be expected:

[0045] A pharmaceutical composition for relieving asthenopi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition capable of alleviating asthenopia and a preparation method of the medicine composition. The medicine composition is prepared from gingko leaves, cowberry blueberry extract, wolfberry fruits, fructus ligustri lucidi, radix polygoni multiflori, flos chrysanthemi, semen cassiae, taurine, zinc gluconate and vitamin A. The medicine composition has the effects of regulating meridians, nourishing liver and tonifying kidney, and clearing liver and improving eyesight; by relaxing blood vessels and eliminating free radicals in retinas, the generation of retina purpurin is promoted, so that the function of alleviating asthenopia is realized; a relative test shows that the medicine composition is reasonable in medicine compatibility, is safe and effective, and has no toxic and side effects; the medicine composition can be used for alleviating asthenopia and improving the sub-health state of people with asthenopia.

Description

technical field [0001] The invention relates to a pharmaceutical composition for alleviating visual fatigue and a preparation method thereof. Background technique [0002] Eye fatigue is a symptom of eye muscle fatigue and nervousness caused by overuse of the eyes or other reasons. These symptoms include: blurred vision, headache, dripping tears, stiff shoulders and nausea. Most ophthalmologists now believe that the disease is based on the patient's conscious eye symptoms, and is a syndrome in which eye or systemic organic factors and mental (psychological) factors are intertwined. Therefore, it is often called eye fatigue syndrome and belongs to the category of psychosomatic medicine. [0003] Asthenopia is similar to liver fatigue syndrome in ophthalmology of traditional Chinese medicine. The name of liver fatigue disease was first seen in "Qian Jin Yao Fang", which refers to an eye disease that causes eye fatigue such as eye swelling, eye pain, dizziness, and orbital p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/815A61P27/02A61K31/185A61K31/315A61K31/07
CPCA61K9/1652A61K31/07A61K31/185A61K31/315A61K36/16A61K36/287A61K36/45A61K36/482A61K36/638A61K36/704A61K36/815A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 何国军
Owner 同溢堂药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap